Ig J chain activators are a class of chemicals that can potentially enhance the functional activity of the J chain protein indirectly through the activation of specific signaling pathways or biological processes that it is directly involved in. The signaling pathways that these chemicals influence include the cAMP/PKA/CREB pathway, the PKC/NF-κB pathway, and the MAPK/ERK pathway. Chemicals like Forskolin, IBMX, 8-Bromo-cAMP, Epinephrine, and Isoproterenol elevate cAMP levels, leading to the activation of PKA and subsequently CREB, which can enhance the expression of the J chain. PMA, BAY 11-7082, and TPA are all involved in the PKC/NF-κB pathway, which can also lead to increased expression of the J chain. Anisomycin and Sodium orthovanadate activate the JNK and MAPK pathways, which can enhance the expression of the J chain through the activation of transcription factors like AP-1. EGF and Bradykinin activate their respective receptors, leading to the activation of the MAPK/ERK pathway and the phospholipase C pathway respectively. These pathways can also enhance the expression of the J chain, leading to its increased functional activity.
These compounds exert their effects through a variety of mechanisms, including receptor agonism, inhibition of phosphodiesterases, and activation of adenylate cyclase among others. The common denominator among all these compounds is their ability to indirectly enhance the function of the J chain by influencing the cellular pathways it is directly involved in. While the exact mechanisms by which these compounds enhance the function of the J chain may vary, they all ultimately lead to the increased expression of the J chain, a critical component of the immune system. Overall, these Ig J chain activators represent a diverse array of chemicals that can potentially enhance the function of the J chain through various biochemical and cellular pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is an activator of adenylate cyclase, which increases cyclic AMP (cAMP) levels in cells. Elevated cAMP can stimulate Protein Kinase A (PKA), a key kinase that phosphorylates and activates CREB. As a transcription factor, CREB can then enhance the expression of the Ig J chain, which could lead to increased functional activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-specific phosphodiesterase (PDE) inhibitor. By inhibiting PDEs, IBMX increases the level of cAMP in cells, which can activate PKA. Activated PKA can phosphorylate and activate CREB, which can enhance the expression of the J chain, leading to its increased functional activity. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a cell-permeable cAMP analog. It can activate PKA, leading to the phosphorylation and activation of CREB. Activated CREB can enhance the expression of the J chain, leading to its increased functional activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is an activator of Protein Kinase C (PKC), which can lead to activation of the NF-κB pathway. Activation of NF-κB can enhance the expression of the J chain, leading to its increased functional activity. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
BAY 11-7082 is an inhibitor of IκBα phosphorylation, which prevents the inhibition of NF-κB. This allows NF-κB to enhance the expression of the J chain, leading to its increased functional activity. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a JNK activator. JNK can phosphorylate and activate c-Jun, part of the AP-1 transcription factor. Activation of AP-1 can enhance the expression of the J chain, leading to its increased functional activity. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Sodium orthovanadate is a tyrosine phosphatase inhibitor. By inhibiting tyrosine phosphatases, it can increase the phosphorylation and activation of proteins in the JNK and MAPK pathways. Activation of these pathways can enhance the expression of the J chain, leading to its increased functional activity. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine is an adrenergic receptor agonist. Activation of adrenergic receptors can increase cAMP levels, leading to PKA activation. PKA can activate CREB, which can enhance the expression of the J chain, leading to increased functional activity. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a non-selective beta-adrenergic agonist. Activation of beta-adrenergic receptors can increase cAMP levels, leading to PKA activation. PKA can activate CREB, which can enhance the expression of the J chain, increasing its functional activity. | ||||||
Bradykinin | 58-82-2 | sc-507311 | 5 mg | $110.00 | ||
Bradykinin is a potent activator of its receptor, B2R. Activation of B2R can stimulate the phospholipase C pathway, leading to PKC activation. PKC can enhance the NF-κB pathway, potentially leading to increased expression of the J chain and increased functional activity. | ||||||